ImmuneOnco Biopharmaceuticals (Shanghai) Inc. (HKG:1541)
Hong Kong · Delayed Price · Currency is HKD 3.520
+0.090 (2.62%)
Jul 10, 2026, 11:53 AM HKT
HKG:1541 Market Cap
HKG:1541 has a market cap or net worth of 1.48 billion as of July 9, 2026. Its market cap has decreased by -73.08% in one year.
Market Cap
1.48B
Enterprise Value
601.73M
Revenue
171.70M
Ranking
n/a
PE Ratio
n/a
Stock Price
3.52
Market Cap Chart
Since September 5, 2023, HKG:1541's market cap has decreased from 7.29B to 1.48B, a decrease of -79.69%. That is a compound annual growth rate of -42.90%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 9, 2026 | 1.48B | -41.17% |
| Dec 31, 2025 | 2.52B | 19.70% |
| Dec 31, 2024 | 2.10B | -81.21% |
| Dec 29, 2023 | 11.19B | 53.55% |
| Sep 5, 2023 | 7.29B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| PegBio | 2.16B |
| AIM Vaccine | 2.01B |
| Clover Biopharmaceuticals | 1.88B |
| Mabpharm | 1.63B |
| SinoMab BioScience | 1.57B |
| Hangzhou Jiuyuan Genetic Biopharmaceutical | 1.51B |
| HighTide Therapeutics | 1.47B |
| Zhaoke Ophthalmology | 1.43B |